Moomoo AI 已提取核心訊息
Raymond M Jordt, the Chief Business Officer of Altimmune, Inc. (ticker: ALT.US), was reported to have engaged in a transaction involving the company's stock on January 25, 2024. Specific details regarding the number of shares transacted, the nature of the shares, the transaction price, and the total value of the transaction were not disclosed in the announcement. Consequently, the number of shares held by Jordt after the transaction remains unknown.
Raymond M Jordt, the Chief Business Officer of Altimmune, Inc. (ticker: ALT.US), was reported to have engaged in a transaction involving the company's stock on January 25, 2024. Specific details regarding the number of shares transacted, the nature of the shares, the transaction price, and the total value of the transaction were not disclosed in the announcement. Consequently, the number of shares held by Jordt after the transaction remains unknown.
據報道，Altimmune, Inc.（股票代碼：ALT.US）的首席商務官雷蒙德·喬德於2024年1月25日參與了一項涉及該公司股票的交易。公告中沒有披露有關交易的股票數量、股票性質、交易價格和交易總價值的具體細節。因此，交易後Jordt持有的股票數量仍然未知。
據報道，Altimmune, Inc.（股票代碼：ALT.US）的首席商務官雷蒙德·喬德於2024年1月25日參與了一項涉及該公司股票的交易。公告中沒有披露有關交易的股票數量、股票性質、交易價格和交易總價值的具體細節。因此，交易後Jordt持有的股票數量仍然未知。
有用
沒用